Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

Cited by (1,000)

Items 601–700 of 1,000

  1. Mdm proteins: critical regulators of embryogenesis and homoeostasis
    Sydney M. Moyer, Connie A. Larsson, Guillermina Lozano · 2017 · Journal of Molecular Cell Biology
  2. The Role of MDM2 in Promoting Genome Stability versus Instability
    Mohammad Reza Saadatzadeh, Adily N. Elmi, Pankita H. Pandya, Khadijeh Bijangi‐Vishehsaraei, Jixin Ding, Christopher W. Stamatkin, Aaron Cohen‐Gadol, Karen E. Pollok · 2017 · International Journal of Molecular Sciences
  3. Competitive ubiquitination activates the tumor suppressor p53
    Xingyao Li, Mengqi Guo, Lun Cai, Tingting Du, Ying Liu, Han‐Fei Ding, Hongbo Wang, Junran Zhang, Xiaoguang Chen, Chunhong Yan · 2019 · Cell Death and Differentiation
  4. The Novel Surveillance Mechanism of the Trp53-Dependent S-Phase Checkpoint Ensures Chromosome Damage Repair and Preimplantation-Stage Development of Mouse Embryos Fertilized with X-Irradiated Sperm
    Tsutomu Shimura, Megumi Toyoshima, Masataka Taga, Kazunori Shiraishi, Norio Uematsu, Masao Inoue, Ohtsura Niwa · 2002 · Radiation Research
  5. MK2 regulates the early stages of skin tumor promotion
    Claus Johansen, Christian Vestergaard, Knud Kragballe, George A. Kollias, Matthias Gaestel, Lars Iversen · 2009 · Carcinogenesis
  6. p53 and p53 ‐regulated genes in bladder cancer
    Keegan, Lunec, David Edgar Neal · 1998 · British Journal of Urology
  7. Iloprost supports early development of in vitro-produced porcine embryos through activation of the phosphatidylinositol 3-kinase/AKT signalling pathway
    Pil‐Soo Jeong, Seung‐Bin Yoon, Seon‐A Choi, Bong‐Seok Song, Ji-Su Kim, Bo‐Woong Sim, Young‐Ho Park, Hae-Jun Yang, Seong-Eun Mun, Younghyun Kim et al. · 2016 · Reproduction Fertility and Development
  8. p53-mediated redox control promotes liver regeneration and maintains liver function in response to CCl4
    Timothy J. Humpton, Holly Hall, Christos Kiourtis, Colin Nixon, William Andrew Clark, Ann Hedley, Robin Shaw, Thomas Graham Bird, Karen Blyth, Karen H. Vousden · 2021 · Cell Death and Differentiation
  9. Anatomy of Mdm2 and Mdm4 in evolution
    Ban Xiong Tan, Hoe Peng Liew, Joy Shijia Chua, Farid John Ghadessy, Yaw Sing Tan, David Philip Lane, Cynthia R. Coffill · 2017 · Journal of Molecular Cell Biology
  10. MDMX Recruits UbcH5c to Facilitate MDM2 E3 Ligase Activity and Subsequent p53 Degradation In Vivo
    Jing Yang, Aiwen Jin, Jing Han, Xin Chen, Junnian Zheng, Yanping Zhang · 2020 · Cancer Research
  11. Evolutionarily conserved transcription factors as regulators of longevity and targets for geroprotection
    Fabian Fischer, Giovanna Grigolon, Christoph Benner, Michael Ristow · 2022 · Physiological Reviews
  12. How the Nucleolar Sequestration of p53 Protein or Its Interplayers Contributes to Its (Re)‐Activation
    Józefa Węsierska‐Gądek, MARCEL HORKYA · 2003 · Annals of the New York Academy of Sciences
  13. MDM2 interacts with the C-terminus of the catalytic subunit of DNA polymerase varepsilon
    Nikolina Vlatković · 2000 · Nucleic Acids Research
  14. Differential Gain-of-Function Activity of Three p53 Hotspot Mutants In Vivo
    Shunbin Xiong, Dhruv Chachad, Yun Zhang, Jovanka Gencel‐Augusto, Mario Sirito, Vinod Pant, Peirong Yang, Chang Sun, Gilda P. Chau, Yuan Qi et al. · 2022 · Cancer Research
  15. Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy
    Jingjie Yi, Omid Tavana, Huan Li, Donglai Wang, Richard J. Baer, Wei Jun Gu · 2023 · Nature Communications
  16. MDM2promoter SNP285 and SNP309; phylogeny and impact on cancer risk
    Stian Knappskog, Per Eystein Lønning · 2011 · Oncotarget
  17. Otub1 stabilizes MDMX and promotes its proapoptotic function at the mitochondria
    Yingxiao Chen, Yue-Gang Wang, Yuhuang Li, Xiao‐Xin Sun, Mu‐Shui Dai · 2016 · Oncotarget
  18. Structural basis for DNA damage-induced phosphoregulation of MDM2 RING domain
    H Magnussen, Syed Feroj Ahmed, Gary J Sibbet, Ventzislava A. Hristova, Koji Nomura, Andreas K. Hock, Lewis J. Archibald, Andrew G. Jamieson, David Fushman, Karen H. Vousden et al. · 2020 · Nature Communications
  19. MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice
    M. Alkhalaf, Gitali Ganguli, Nadia Messaddeq, Marianne LeMeur, Bohdan Wasylyk · 1999 · Oncogene
  20. MDM4 (MDMX) Overexpression Enhances Stabilization of Stress-induced p53 and Promotes Apoptosis
    Francesca Mancini, Francesca Gentiletti, Marco D'Angelo, Simona Giglio, Simona Nanni, Carmen D’Angelo, Antonella Farsetti, Gennaro Citro, Ada Sacchi, Alfredo Pontecorvi et al. · 2004 · Journal of Biological Chemistry
  21. Accentuated apoptosis in normally developing p53 knockout mouse embryos following genotoxic stress
    Jene Frenkel, Dan Sherman, Amos Fein, Dov Schwartz, Nava Almog, Ahuva Kapon, Naomi Goldfinger, Varda Rotter · 1999 · Oncogene
  22. Full-length hdmX transcripts decrease following genotoxic stress
    Markey, M, Berberich, S J · 2008 · Oncogene
  23. MDM2 and MDMX in Cancer and Development
    Jean‐Christophe Marine · 2011 · Current topics in developmental biology/Current Topics in Developmental Biology
  24. Identification and characterization of an oocyte factor required for development of porcine nuclear transfer embryos
    Kei Miyamoto, Kouhei Nagai, Naoya Kitamura, Tomoaki Nishikawa, Haruka Ikegami, Nguyen T. Binh, Satoshi Tsukamoto, Mai Matsumoto, Tomoyuki Tsukiyama, Naojiro Minami et al. · 2011 · Proceedings of the National Academy of Sciences
  25. Switching on p53: an essential role for protein phosphorylation?
    Jayne Loughery, David W. Meek · 2013 · Biodiscovery
  26. Mdm2: Open questions
    Matthias Dobbelstein, Arnold J. Levine · 2020 · Cancer Science
  27. DGKζ under stress conditions: “To be nuclear or cytoplasmic, that is the question”
    Kaoru Goto, Toshiaki Tanaka, Tomoyuki Nakano, Masashi Okada, Yasukazu Hozumi, Matthew K. Topham, Alberto Maria Martelli · 2013 · Advances in Biological Regulation
  28. ATM activity contributes to the tumor-suppressing functions of p14ARF
    Yanxia Li, Dongcheng Wu, Biao Chen, Alistair John Ingram, Lizhi He, Lieqi Liu, Dahai Zhu, Anil Kapoor, Damu Tang · 2004 · Oncogene
  29. Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System
    Manuel Nieto‐Sampedro, Beatriz Valle‐Argos, Diego Gómez‐Nicola, Alfonso Fernández‐Mayoralas, Manuel Nieto‐Díaz · 2011 · Clinical Medicine Insights Oncology
  30. Dying to Survive—The p53 Paradox
    Andrea Lees, Tamas Sessler, Simon S. McDade · 2021 · Cancers
  31. p53 activation by knockdown technologies
    Mara E. Robu, Jon D. Larson, Aidas Nasevicius, Soraya Beiraghi, Charles Brenner, Steven Arthur Farber, Stephen Carl Ekker · 2005 · PLoS Genetics
  32. Corp Regulates P53 in Drosophila melanogaster via a Negative Feedback Loop
    Riddhita Chakraborty, Ying Li, Lei Ji Zhou, Kent G. Golic · 2015 · PLoS Genetics
  33. High-Resolution Array-Based Comparative Genomic Hybridization of Bladder Cancers Identifies Mouse Double Minute 4 ( MDM4 ) as an Amplification Target Exclusive of MDM2 and TP53
    Abhi Veerakumarasivam, Helen E. Scott, Suet‐Feung Chin, Anne Yvonne Warren, Matthew J. Wallard, Donna Grimmer, Koichi Ichimura, Carlos Caldas, Vincent Peter Collins, David Edgar Neal et al. · 2008 · Clinical Cancer Research
  34. Mouse bites dogma: how mouse models are changing our views of how P53 is regulated in vivo
    Geoffrey M. Wahl · 2006 · Cell Death and Differentiation
  35. p53 from pathway to therapy
    David Philip Lane · 2004 · Carcinogenesis
  36. p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts
    Kazuo Kurokawa, Toshiaki Tanaka, Jun‐ya Kato · 1999 · Oncogene
  37. Gene disruption in mice: Models of development and disease
    Barkur S. Shastry · 1998 · Molecular and Cellular Biochemistry
  38. A repressor function for telomerase activity in telomerase-negative immortal cells
    Motonobu Katoh, M Katoh, Michihiro Kameyama, Hiroyuki Kugoh, Motoyuki Shimizu, Mitsuo Oshimura · 1998 · Molecular Carcinogenesis
  39. DNA damage-induced activation of ATM promotes β-TRCP-mediated Mdm2 ubiquitination and destruction
    Zhiwei Peter Wang, Hiroyuki Inuzuka, Jiateng Zhong, Hidefumi Fukushima, Lixin Wan, Pengda Liu, Wenyi Wei · 2012 · Oncotarget
  40. Negative auto-regulators trap p53 in their web
    Xiang Yu Zhou, Bo Cao, Hua Lu · 2017 · Journal of Molecular Cell Biology
  41. Optimal Affinity Enhancement by a Conserved Flexible Linker Controls p53 Mimicry in MdmX
    Wade M. Borcherds, Andreas Becker, Lihong Chen, Jiandong Chen, Lucia Beatriz Chemes, Gary W. Daughdrill · 2017 · Biophysical Journal
  42. Novel roles of ER stress in repressing neural activity and seizures through Mdm2- and p53-dependent protein translation
    Dai-Chi Liu, Daphne E. Eagleman, Nien‐Pei Tsai · 2019 · PLoS Genetics
  43. Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer
    Wen Li, Xinhao Peng, Jinyi Lang, Chuan Shan Xu · 2020 · Frontiers in Pharmacology
  44. Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching
    Sylvia A. Hilliard, Karam Aboudehen, Xiao Yao, Samir Sayem El-Dahr · 2011 · Developmental Biology
  45. Induction of Cullin 7 by DNA damage attenuates p53 function
    Peter Jung, Berlinda Verdoodt, Aaron Oakley Bailey, John R. Yates, Antje Menssen, Heiko Hermeking · 2007 · Proceedings of the National Academy of Sciences
  46. Effects of in vitro fertilization and embryo culture on TRP53 and Bax expression in B6 mouse embryos
    Vashe Chandrakanthan, Aiqing Li, Omar Chami, C. O’Neill · 2006 · Reproductive Biology and Endocrinology
  47. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.
    Hai Liang Yang, Yan Dong, Mary Jane Elliott, Ta Jen Liu, Cesar A. Atienza, Ariel Stilwell, Kelly M. McMasters · 1999 · PubMed
  48. Widespread Overexpression of Epitope-Tagged Mdm4 Does Not Accelerate Tumor Formation In Vivo
    De Clercq, Sarah, Gembarska, Agnieszka, Denecker, Geertrui, Maetens, Marion, Naessens, Michael, Haigh, Katharina, Haigh, Jody J., Marine, Jean-Christophe · 2010 · Molecular and Cellular Biology
  49. The p53-Mdm2 Loop: A Critical Juncture of Stress Response
    Yaara Levav-Cohen, Zehavit Goldberg, Kah Hin Tan, Osnat Alsheich-Bartok, Valentina Zuckerman, Sue Haupt, Ygal Haupt · 2014 · Sub-cellular biochemistry/Subcellular biochemistry
  50. Battle Against Cancer: An Everlasting Saga of p53
    Qian Hao, William Cho · 2014 · International Journal of Molecular Sciences
  51. Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy
    Ishita Gupta, Nishant Kumar Varshney, Sameena M. Khan · 2018 · Frontiers in Genetics
  52. Absence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growth
    Heather A. Steinman, Hayla K. Sluss, Arthur Sands, German Albert Pihan, Stephen N. Jones · 2004 · Oncogene
  53. Cytoplasmic localization of DGKζ exerts a protective effect against p53-mediated cytotoxicity
    Toshiaki Tanaka, Masashi Okada, Yasukazu Hozumi, Ken Tachibana, Chifumi Kitanaka, Yoshioki Hamamoto, Alberto Maria Martelli, Matthew K. Topham, Mitsuyoshi Iino, Kaoru Goto · 2013 · Journal of Cell Science
  54. Functions of p53 in metabolism and invasion
    Karen H. Vousden · 2009 · Biochemical Society Transactions
  55. Up-regulation of murine double minute clone 2 (MDM2) gene expression in rat brain after morphine, heroin, and cocaine administrations
    Yan Jiang, Weilin Yang, Yuqing Zhou, Lan Ma · 2003 · Neuroscience Letters
  56. Regulation of the Retinoblastoma-Dependent Mdm2 and E2F-1 Signaling Pathways during Neuronal Apoptosis
    Emmanuelle Trinh, Anne‐Laurence Boutillier, Jean‐Philippe Loeffler · 2001 · Molecular and Cellular Neuroscience
  57. Central and carboxy‐terminal regions of human p53 protein are essential for interaction and complex formation with PARP‐1
    Józefa Węsierska‐Gądek, Jacek Wojciechowski, Gerald Schmid · 2003 · Journal of Cellular Biochemistry
  58. The contribution of the RING finger domain of MDM2 to cell cycle progression
    Manuela Argentini, Nadia Barboule, Bohdan Wasylyk · 2000 · Oncogene
  59. MdmX regulates transformation and chromosomal stability in p53-deficient cells
    Matijasevic, Zdenka, Krzywicka-Racka, Anna, Sluder, Greenfield, Jones, Stephen N. · 2008 · Cell Cycle
  60. Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis
    Michael I. Carr, Justine E. Roderick, Hugh Gannon, Michelle A. Kelliher, Stephen N. Jones · 2016 · Cell Reports
  61. SMG7 is a critical regulator of p53 stability and function in DNA damage stress response
    Hongwei Luo, Lauren E. Cowen, Guowu Yu, Wen G. Jiang, Yi Tang · 2016 · Cell Discovery
  62. Mdm2 regulates cardiac contractility by inhibiting GRK2-mediated desensitization of β-adrenergic receptor signaling
    Pierre‐Yves Jean‐Charles, Samuel Mon-Wei Yu, Dennis Abraham, Reddy Peera Kommaddi, Lan Mao, Ryan T. Strachan, Zhu-Shan Zhang, Dawn E. Bowles, Leigh Brian, Jonathan A. Stiber et al. · 2017 · JCI Insight
  63. The Role of single- and multi-walled Carbon Nanotube in Breast Cancer Treatment
    Babak Faraji Dizaji, Amirnezam Farboudi, Alireza Rahbar, Mohammadreza Hasani Azarbaijan, Mohammad Reza Asgary · 2020 · Therapeutic Delivery
  64. MDM2 as MYCN transcriptional target: Implications for neuroblastoma pathogenesis
    Andrew Slack, Guillermina Lozano, Jason Matthew Shohet · 2005 · Cancer Letters
  65. Dual action of the inhibitors of cyclin-dependent kinases: targeting of the cell-cycle progression and activation of wild-type p53 protein
    Józefa Węsierska‐Gądek, Gerald Schmid · 2005 · Expert Opinion on Investigational Drugs
  66. Limited role of N-terminal phosphoserine residues in the activation of transcription by p53
    Mark W. Jackson, Mukesh K. Agarwal, Munna L. Agarwal, Archana M. Agarwal, Patricia Stanhope-Baker, Bryan R.G. Williams, George Robert Stark · 2004 · Oncogene
  67. Direct Evidence for the Action of Phosphatidylinositol (3,4,5)-Trisphosphate-Mediated Signal Transduction in the 2-Cell Mouse Embryo1
    Yan Li, Vashe Chandrakanthan, Margot L. Day, Chris O’Neill · 2007 · Biology of Reproduction
  68. Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression.
    Raymond D. Meng, Helen Alice Shih, N S Prabhu, Donna L. George, Wafik S. El‐Deiry · 1998 · PubMed
  69. The roles of MDM2 and MDMX phosphorylation in stress signaling to p53
    Chen, J. · 2012 · Genes & Cancer
  70. Apoptosis of Sertoli cells after conditional ablation of murine double minute 2 (Mdm2) gene is p53-dependent and results in male sterility
    Sophie Fouchécourt, Gabriel Livera, Sébastien Messiaen, Betty Fumel, A-S Parent, Jean‐Christophe Marine, Philippe Monget · 2015 · Cell Death and Differentiation
  71. p53mRNA and p53 Protein Structures Have Evolved Independently to Interact with MDM2
    Konstantinos Karakostis, Anand Ponnuswamy, Leïla T. S. Fusée, Xavier Bailly, Laurent Laguerre, Erin G. Worrall, Borek Vojtesek, Karin Nylander, Robin Fåhræus · 2016 · Molecular Biology and Evolution
  72. The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination
    Monica Cubillos‐Rojas, Taiane Schneider, Ouadah Hadjebi, Leonardo Pedrazza, Jarbas Rodrigues de Oliveira, Francina Langa Vives, Jean‐Louis Guénet, Joan Duran, Josep Maria de Anta, Soledad Alcántara et al. · 2016 · Oncotarget
  73. Germ cell determination and the developmental origin of germ cell tumors
    Peter K. Nicholls, David C. Page · 2021 · Development
  74. MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity
    Meenalakshmi Chinnam, Chao Xu, Rati Lama, Xiaojing Zhang, Carlos D. Cedeno, Yanqing Wang, Aimee B. Stablewski, David W. Goodrich, Xinjiang Wang · 2022 · PLoS Genetics
  75. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development
    Christine M. Eischen, Jodi R. Alt, Peng Wang · 2004 · Oncogene
  76. The expression of the mdm2 gene may be related to the aberration of the p53 gene in human hepatocellular carcinoma
    Shuang‐Jian Qiu, Sheng-Long Ye, Zhi-Quan Wu, Zhao–You Tang, Yin-Kun Liu · 1998 · Journal of Cancer Research and Clinical Oncology
  77. Abnormal MDMX degradation in tumor cells due to ARF deficiency
    Li, X, Gilkes, D, Li, B, Cheng, Q, Pernazza, D, Lawrence, H, Lawrence, N, Chen, J · 2012 · Oncogene
  78. Caudal regression in adrenocortical dysplasia (acd) mice is caused by telomere dysfunction with subsequent p53-dependent apoptosis
    Vlangos, Christopher N., O'Connor, Bridget C., Morley, Madeleine J., Krause, Andrea S., Osawa, Gail A., Keegan, Catherine E. · 2009 · Developmental Biology
  79. Inhibitors of MDM2 and MDMX: A Structural Perspective
    Christiane Riedinger, James M. McDonnell · 2009 · Future Medicinal Chemistry
  80. UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation
    Cheng Du, Hong Wu, Roger P. Leng · 2015 · Oncotarget
  81. The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2 T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells
    Yajian Duan, Gaoen Ma, Xionggao Huang, Patrìcia A. D'Amore, Feng Zhang, Hetian Lei · 2016 · Journal of Biological Chemistry
  82. The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumourigenesis
    Shunbin Xiong, Vinod Pant, Yun Zhang, Neeraj K. Aryal, Mingjian James You, Donna F. Kusewitt, Guillermina Lozano · 2016 · The Journal of Pathology
  83. Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2
    Shilpa Yadahalli, José L. Neira, Christopher M. Johnson, Yaw Sing Tan, Pamela J. E. Rowling, Anasuya Chattopadhyay, Chandra Shekhar Verma, Laura S. Itzhaki · 2019 · Scientific Reports
  84. Prospects for p53-based cancer therapy.
    Tomasz Stokłosa, Jakub Gołąb · 2005 · Acta Biochimica Polonica
  85. Stochastic Modeling and Simulation of the p53-MDM2/MDMX Loop
    Xiaodong Cai, Zhi-Min Yuan · 2009 · Journal of Computational Biology
  86. Substrate Phosphorylation and Feedback Regulation in JFK-promoted p53 Destabilization
    Luyang Sun, Lei Shi, Feng Wang, Peiwei Huangyang, Wenzhe Si, Jie Yang, Zhi Yao, Yongfeng Shang · 2010 · Journal of Biological Chemistry
  87. A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer
    Diptee A. Kulkarni, Alexei Vázquez, Bruce George Haffty, Elisa Victoria Bandera, Wenwei Hu, Yvonne Sun, Deborah Toppmeyer, Arnold J. Levine, Kim Marie Hirshfield · 2009 · Carcinogenesis
  88. Dimerization of CUL7 and PARC Is Not Required for All CUL7 Functions and Mouse Development
    Jeffrey Rolf Skaar, Takehiro Arai, James A. DeCaprio · 2005 · Molecular and Cellular Biology
  89. Mouse Models for Sporadic Cancer
    Ralph Leo Johan Meuwissen, Jos Jonkers, Anton J. M. Berns · 2001 · Experimental Cell Research
  90. Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers
    Chen Katz, Ana María Low-Calle, Joshua H. Choe, Oleg Laptenko, David Tong, Jazmine-Saskya N. Joseph-Chowdhury, Francesca Garofalo, Yan Yu Zhu, Assaf Friedler, Carol L. Prives · 2018 · Genes & Development
  91. The ups and downs of p53 regulation in hematopoietic stem cells
    Hussein A. Abbas, Vinod Pant, Guillermina Lozano · 2011 · Cell Cycle
  92. Activation of cAMP Signaling Interferes with Stress-Induced p53 Accumulation in ALL-Derived Cells by Promoting the Interaction between p53 and HDM2
    Elin Hallan Naderi, Aart G. Jochemsen, Heidi Kiil Blomhoff, Soheil Naderi · 2011 · Neoplasia
  93. Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses
    Oleg N. Timofeev, Boris Klimovich, Jean Schneikert, Michael Wanzel, Evangelos Pavlakis, Julia Noll, Samet Mutlu, Sabrina Elmshäuser, Andrea Nist, Marco Mernberger et al. · 2019 · The EMBO Journal
  94. Mtbp haploinsufficiency in mice increases tumor metastasis
    Tomoo Iwakuma, Y Tochigi, Carolyn S. Van Pelt, Lisa C. Caldwell, Tamara Terzian, John M. Parant, Gilda P. Chau, Joanna Gail Koch, Christine M. Eischen, Guillermina Lozano · 2007 · Oncogene
  95. Nucleo-cytoplasmic shuttling of the HDM2 oncoprotein regulates the levels of P53 protein VIA a pathway USED by the human immunodeficiency virus REV protein
    J. Roth, Matthias Dobbelstein, D. Freedman, Thomas E. Shenk, Arnold J. Levine · 1998 · Gastroenterology
  96. Evidence that the Human Cytomegalovirus IE2-86 Protein Binds mdm2 and Facilitates mdm2 Degradation
    Zhigang Zhang, David L. Evers, Joseph F. McCarville, Jean-Christophe Dantonel, Shu‐Mei Huong, Eng‐Shang Huang · 2006 · Journal of Virology
  97. Manipulating the germline: its impact on the study of carcinogenesis
    Alan Richard Clarke · 2000 · Carcinogenesis
  98. The Mdm2 gene of zebrafish (Danio rerio): preferential expression during development of neural and muscular tissues, and absence of tumor formation after overexpression of its cDNA during early embryogenesis
    Henry Neel, Sylvain Daujat, Jacques Piette, Christine Thisse, Bernard Thisse · 2000 · Differentiation
  99. Increased Mdm2 Expression in Rat Brain after Transient Middle Cerebral Artery Occlusion
    Yahong Tu, Sheng‐Tao Hou, Zhigao Huang, George S. Robertson, John P. MacManus · 1998 · Journal of Cerebral Blood Flow & Metabolism
  100. The role of mRNA decay in p53-induced gene expression
    Brian D. Melanson, Reetesh Bose, Jeff D. Hamill, Kristen A. Marcellus, Elysia Pan, Bruce C. McKay · 2011 · RNA